These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 18297287

  • 1. Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell.
    Wei SH, Dong K, Lin F, Wang X, Li B, Shen JJ, Zhang Q, Wang R, Zhang HZ.
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1055-64. PubMed ID: 18297287
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway.
    Yao J, Qian C.
    Med Oncol; 2010 Sep; 27(3):1017-22. PubMed ID: 19816816
    [Abstract] [Full Text] [Related]

  • 3. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.
    Jiang C, Yi XP, Shen H, Li YX.
    World J Gastroenterol; 2012 Jun 21; 18(23):2956-65. PubMed ID: 22736919
    [Abstract] [Full Text] [Related]

  • 4. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
    Venkatasubbarao K, Peterson L, Zhao S, Hill P, Cao L, Zhou Q, Nawrocki ST, Freeman JW.
    Mol Cancer; 2013 Sep 11; 12(1):104. PubMed ID: 24025152
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
    Huang L, Hu C, Cao H, Wu X, Wang R, Lu H, Li H, Chen H.
    Cell Physiol Biochem; 2018 Sep 11; 47(2):747-758. PubMed ID: 29807360
    [Abstract] [Full Text] [Related]

  • 6. RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells.
    Yu C, Zhang X, Sun G, Guo X, Li H, You Y, Jacobs JL, Gardner K, Yuan D, Xu Z, Du Q, Dai C, Qian Z, Jiang K, Zhu Y, Li QQ, Miao Y.
    J Cell Mol Med; 2008 Dec 11; 12(6A):2334-49. PubMed ID: 18266952
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
    Chen D, Niu M, Jiao X, Zhang K, Liang J, Zhang D.
    Int J Mol Sci; 2012 Dec 11; 13(1):1186-1208. PubMed ID: 22312312
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression.
    Tang K, Zhang Z, Bai Z, Ma X, Guo W, Wang Y.
    Oncol Rep; 2011 Apr 11; 25(4):963-70. PubMed ID: 21225236
    [Abstract] [Full Text] [Related]

  • 9. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.
    Wang M, Lu X, Dong X, Hao F, Liu Z, Ni G, Chen D.
    World J Surg Oncol; 2015 Feb 21; 13():66. PubMed ID: 25880226
    [Abstract] [Full Text] [Related]

  • 10. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.
    Shi X, Liu S, Kleeff J, Friess H, Büchler MW.
    Oncology; 2002 Feb 21; 62(4):354-62. PubMed ID: 12138244
    [Abstract] [Full Text] [Related]

  • 11. Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer.
    Chun SG, Zhou W, Yee NS.
    Cancer Biol Ther; 2009 Jul 21; 8(14):1328-39. PubMed ID: 19421011
    [Abstract] [Full Text] [Related]

  • 12. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
    Zhang Z, Wang F, Du C, Guo H, Ma L, Liu X, Kornmann M, Tian X, Yang Y.
    Cancer Lett; 2017 Aug 28; 402():213-224. PubMed ID: 28602977
    [Abstract] [Full Text] [Related]

  • 13. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine.
    Gao CC, Xu XL, Li F, Gong BG, Liu S, Cui YQ, Sun HC, Xu PY, Zheng YM, Jiang H.
    Tumour Biol; 2016 Jun 28; 37(6):7555-64. PubMed ID: 26684804
    [Abstract] [Full Text] [Related]

  • 14. Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicity.
    Bauer C, Hees C, Sterzik A, Bauernfeind F, Mak'Anyengo R, Duewell P, Lehr HA, Noessner E, Wank R, Trauzold A, Endres S, Dauer M, Schnurr M.
    J Immunother; 2015 Apr 28; 38(3):116-26. PubMed ID: 25751501
    [Abstract] [Full Text] [Related]

  • 15. BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance.
    Wang YH, Sui YN, Yan K, Wang LS, Wang F, Zhou JH.
    Oncol Rep; 2015 Apr 28; 33(4):1699-706. PubMed ID: 25647019
    [Abstract] [Full Text] [Related]

  • 16. Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells.
    Niu W, Liu X, Zhang Z, Xu K, Chen R, Liu E, Wang J, Peng C, Niu J.
    Anticancer Res; 2010 Jan 28; 30(1):135-42. PubMed ID: 20150628
    [Abstract] [Full Text] [Related]

  • 17. DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine.
    Liu F, Gore AJ, Wilson JL, Korc M.
    PLoS One; 2014 Jan 28; 9(1):e84982. PubMed ID: 24409315
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor 1 receptor promotes the growth and chemoresistance of pancreatic cancer.
    Tian X, Hao K, Qin C, Xie K, Xie X, Yang Y.
    Dig Dis Sci; 2013 Sep 28; 58(9):2705-12. PubMed ID: 23589145
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.
    Biliran H, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH, Liao JD.
    Clin Cancer Res; 2005 Aug 15; 11(16):6075-86. PubMed ID: 16115953
    [Abstract] [Full Text] [Related]

  • 20. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
    Liu J, Ma J, Wu Z, Li W, Zhang D, Han L, Wang F, Reindl KM, Wu E, Ma Q.
    BMC Cancer; 2014 Sep 20; 14():686. PubMed ID: 25240403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.